Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Seven days triple therapy for eradication of Helicobacter pylori does not alter the disease activity of patients with inflammatory bowel disease.
Shinzaki S, Fujii T, Bamba S, Ogawa M, Kobayashi T, Oshita M, Tanaka H, Ozeki K, Takahashi S, Kitamoto H, Kani K, Nanjo S, Sugaya T, Sakakibara Y, Inokuchi T, Kakimoto K, Yamada A, Yasuhara H, Yokoyama Y, Yoshino T, Matsui A, Nakamura M, Tomizawa T, Sakemi R, Kamata N, Hibi T. Shinzaki S, et al. Among authors: takahashi s. Intest Res. 2018 Oct;16(4):609-618. doi: 10.5217/ir.2018.00044. Epub 2018 Oct 10. Intest Res. 2018. PMID: 30301329 Free PMC article.
Slight increases in the disease activity index and platelet count imply the presence of active intestinal lesions in C-reactive protein-negative Crohn's disease patients.
Nakarai A, Kato J, Hiraoka S, Inokuchi T, Takei D, Morito Y, Akita M, Takahashi S, Hori K, Harada K, Okada H, Yamamoto K. Nakarai A, et al. Among authors: takahashi s. Intern Med. 2014;53(17):1905-11. doi: 10.2169/internalmedicine.53.2627. Epub 2014 Sep 1. Intern Med. 2014. PMID: 25175121 Free article.
Real-world Experience of Anti-tumor Necrosis Factor Therapy for Internal Fistulas in Crohn's Disease: A Retrospective Multicenter Cohort Study.
Kobayashi T, Hishida A, Tanaka H, Nuki Y, Bamba S, Yamada A, Fujii T, Shinzaki S, Yokoyama Y, Yoshida A, Ozeki K, Ashizuka S, Kamata N, Nanjo S, Kakimoto K, Nakamura M, Matsui A, Yamauchi R, Takahashi S, Tomizawa T, Yoshino T, Hibi T. Kobayashi T, et al. Among authors: takahashi s. Inflamm Bowel Dis. 2017 Dec;23(12):2245-2251. doi: 10.1097/MIB.0000000000001276. Inflamm Bowel Dis. 2017. PMID: 29084079
Long-term outcomes of patients with Crohn's disease who received infliximab or adalimumab as the first-line biologics.
Inokuchi T, Takahashi S, Hiraoka S, Toyokawa T, Takagi S, Takemoto K, Miyaike J, Fujimoto T, Higashi R, Morito Y, Nawa T, Suzuki S, Nishimura M, Inoue M, Kato J, Okada H. Inokuchi T, et al. Among authors: takahashi s. J Gastroenterol Hepatol. 2019 Aug;34(8):1329-1336. doi: 10.1111/jgh.14624. Epub 2019 Feb 27. J Gastroenterol Hepatol. 2019. PMID: 30724387
Risk Factors for Mortality in Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease.
Yoshida A, Kamata N, Yamada A, Yokoyama Y, Omori T, Fujii T, Hayashi R, Kinjo T, Matsui A, Fukata N, Takahashi S, Sakemi R, Ogata N, Ashizuka S, Bamba S, Ooi M, Kanmura S, Endo K, Yoshino T, Tanaka H, Morizane T, Shinzaki S, Kobayashi T. Yoshida A, et al. Among authors: takahashi s. Inflamm Intest Dis. 2019 Apr;3(4):167-172. doi: 10.1159/000495035. Epub 2019 Feb 6. Inflamm Intest Dis. 2019. PMID: 31111032 Free PMC article.
Observer agreement for the diagnosis of intestinal acute graft-vs.-host disease based on the presence of villous atrophy in the terminal ileum.
Sugihara Y, Hiraoka S, Yasutomi E, Oka S, Yamasaki Y, Inokuchi T, Kinugasa H, Takahara M, Morito Y, Takahashi S, Harada K, Tanaka T, Otsuka F, Okada H. Sugihara Y, et al. Among authors: takahashi s. Exp Ther Med. 2020 Apr;19(4):3076-3080. doi: 10.3892/etm.2020.8538. Epub 2020 Feb 21. Exp Ther Med. 2020. PMID: 32256795 Free PMC article.
11,166 results
You have reached the last available page of results. Please see the User Guide for more information.